(Q42621322)

3 November 2017

Two mutations affecting conserved residues in the Met receptor operate via different mechanisms (English)

1 reference

3 November 2017

Maritano D

1

1 reference

3 November 2017

Accornero P

series ordinal

2

1 reference

3 November 2017

Bonifaci N

series ordinal

3

1 reference

3 November 2017

Ponzetto C

series ordinal

4

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

3 November 2017

1 reference

3 November 2017

19

1 reference

3 November 2017

1354-1361

1 reference

3 November 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203431

3 November 2017

0 references

cites work

"Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Molecular cloning of a new transforming gene from a chemically transformed human cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

A point mutation in the MET oncogene abrogates metastasis without affecting transformation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Autoregulatory mechanisms in protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Crystal structure of the tyrosine kinase domain of the human insulin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Activating mutations for the met tyrosine kinase receptor in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

The mutationally activated Met receptor mediates motility and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Receptor signaling: when dimerization is not enough

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Emerging multipotent aspects of hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Mechanism of met oncogene activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Scatter factor/hepatocyte growth factor is essential for liver development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

One gene—four syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Switching signals on or off by receptor dimerization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Expression and characterization of biologically active human hepatocyte growth factor (HGF) by insect cells infected with HGF-recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203431

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203431

1 reference

Dimensions Publication ID

3 November 2017

0 references

1 reference